Global framework on essential health R&D
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference5 articles.
1. Drug development output from 1975 to 1996: what output for tropical diseases?;Trouiller;Int J Infect Dis,1999
2. Access to essential drugs: a lost battle?;Pécoul;JAMA,1999
3. Drug development for neglected diseases;Trouiller;Lancet,2002
4. The new landscape of neglected diseases drug development;Moran,2005
Cited by 132 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Globalization of clinical research in oncology: Status, challenges, and future directions;Journal of Cancer Policy;2024-12
2. Conducting Drug Treatment Trials in Children: Opportunities and Challenges;Pharmaceutical Medicine;2024-05
3. Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox;Journal of Pharmaceutical Sciences;2023-06
4. Bioethics and sociology: the place of social studies of science and technology;Interface - Comunicação, Saúde, Educação;2023
5. D’une pandémie à l’autre, rareté artificielle et rente sous brevet de médicament;Économie et Institutions;2022-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3